首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer

【2h】

A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer

机译：卡培他滨节律化疗作为转移性结直肠癌诱导治疗后应答者维持策略的一项研究不亚于常规化疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Study design and flowchart. mCRC, metastatic colorectal cancer; ECOG, Eastern Cooperative Oncology Group; SD, stable disease; PR, partial response; CR, complete response; PD, progression of disease; PFS, progression-free survival; OS, overall survival

机译：研究设计和流程图。 mCRC，转移性大肠癌；东部合作肿瘤小组ECOG； SD，疾病稳定； PR，部分反应； CR，完整的回应； PD，疾病进展； PFS，无进展生存期；操作系统，整体生存

著录项

期刊名称 Current Controlled Trials in Cardiovascular Medicine
作者
Min Shi; Tao Ma; Wenqi Xi; Jinling Jiang; Junwei Wu; Chenfei Zhou; Chen Yang; Zhenggang Zhu; Jun Zhang;
展开▼
作者单位

展开▼
年(卷),期 2020(21),-1
年度 2020
页码 -1
总页数 7
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
Metronomic chemotherapy; Capecitabine; Maintenance treatment; Metastatic colorectal cancer;

机译：节律化疗;卡培他滨;维持治疗;转移性大肠癌;

相似文献

外文文献
中文文献
专利

1. A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer [J] . Min Shi, Tao Ma, Wenqi Xi, Trials . 2020,第1期

机译：对Capecitabine Menronomic Chemothapy的研究是常规化疗，作为转移性结直肠癌诱导治疗后响应者的维持策略
2. Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial [J] . Cremolini Chiara, Malmorino Federica, Bergamo Francesca, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2019,第期

机译：第II期随机研究用Bevacizumab或Bevacizumab加上一流诱导叶昔昔昔单乳蛋白酶转移结直肠癌患者的牛伐单抗和贝伐单抗化疗研究：MOMA试验
3. A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first-line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial [J] . Hagman H., Frodin J. -E., Berglund A., Annals of oncology: official journal of the European Society for Medical Oncology . 2016,第1期

机译：一线诱导治疗转移性结直肠癌后用贝伐单抗，厄洛替尼或卡培他滨治疗的KRAS指导维持治疗的随机研究：Nordic ACT2试验
4. Is High-Dose Chemotherapy Plus Stem-Cell Transplant the Standard Treatment for Patients Failing First-Line Chemotherapy for Metastatic Germ Cell Tumor? [C] . Christian Kollmannsberger, Lawrence Einhorn, Craig Nichols Genitourinary Cancers Symposium. . 2014

机译：高剂量化疗加干细胞移植对转移细胞肿瘤的一线化疗失败的患者的标准治疗吗？
5. Metronomic Chemotherapy and Immunotherapy for Triple Negative Breast Cancer [D] . Lopez, Candice. 2020

机译：用于三重阴性乳腺癌的度量组化疗和免疫疗法
6. Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage [O] . Xiuwen Guan, Fei Ma, Xiaoying Sun, 2020

机译：肠道微生物症患者患有HER2阴性转移性乳腺癌患者接受杂志化化疗的含量与常规剂量
7. Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage [O] . Xiuwen Guan, Fei Ma, Xiaoying Sun, 2020

机译：肠道微生物症患者患有HER2阴性转移性乳腺癌患者，接受杂志化化疗的含量与常规剂量

A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer

摘要

著录项

相似文献

相关主题

期刊订阅